Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ARIPIPRAZOLE MONOHYDRATE, with a corresponding US DMF Number 31257.
Remarkably, this DMF maintains an Active status since its submission on December 30, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 03, 2021, and payment made on August 18, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II